Neotiv
Neotiv GmbH is a German digital health company developing the neotivCare® app, a CE-certified medical device that uses digital memory tests to detect early signs of cognitive impairment and Alzheimer's disease in at-risk individuals.
- Company typePrivate
- Founded2017
- HeadquartersMagdeburg, Germany
- Headcount11–50
- GTM typeB2C
- OfferingSoftware
Neotiv firmographics
Firmographics- Name
- Neotiv
- Legal name
- Neotiv GmbH
- Website
- https://neotiv.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Neotiv GmbH is a German digital health company developing the neotivCare® app, a CE-certified medical device that uses digital memory tests to detect early signs of cognitive impairment and Alzheimer's disease in at-risk individuals.
- Ownership category
- akta.pro rank
Neotiv industry classification
Industry- Product category
- Digital Health / Cognitive Diagnostics
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
- akta.pro secondary industry
- Cognitive Stimulation & Reminiscence Therapy (Non-Clinical) (HSABAEAH)
Keywords
Where Neotiv is headquartered
LocationHeadquarters
- HQ city
- Magdeburg
- HQ country
- Germany
- HQ region
- Europe
Markets served
Neotiv business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Neotiv product offering
Product offeringCore offering
Neotiv develops and distributes the neotivCare® app, a CE-certified medical device that administers digital memory tests on a mobile platform to identify cognitive impairment at an early stage and support early Alzheimer's detection. The product targets individuals at risk of cognitive decline and is positioned as an accessible, non-invasive early screening tool for cognitive health.
Differentiator
Problem solved
Functional benefit
Brands
- neotivCare®: A CE-certified medical device app that utilizes digital memory tests to identify cognitive impairment at an early stage for Alzheimer's detection.
Products and services
- neotivCare® App A CE-certified medical device mobile application that administers digital memory tests to identify cognitive impairment at an early stage, enabling early Alzheimer's detection. Targeted at individuals at risk for cognitive decline and supporting healthcare providers in early cognitive screening.
Companies that use Neotiv
Customer profileSegments1 record
Ideal customer profiles1 record
Neotiv technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Neotiv partnerships and signals
Strategic signalScale indicators1 record
Neotiv competitors and assessment
Company assessmentDirect peers
- Cambridge Cognition: Provides CANTAB, a computerized cognitive testing platform widely used in clinical trials and clinical practice. Most directly comparable to Neotiv in offering validated, digital memory and cognitive assessment tools targeting Alzheimer's and other CNS indications.
- Cogstate: Commercializes computerized cognitive tests used in clinical trials and healthcare. Directly comparable to Neotiv as a digital cognitive assessment vendor serving both research and clinical customers in neurodegenerative disease.
Emerging players
- Altoida: Develops a digital biomarker platform for early Alzheimer's detection using smartphone-based cognitive tasks and AR. Closely aligned with Neotiv on mobile-first, digital memory testing for pre-symptomatic cognitive decline.
- Linus Health: Offers a digital cognitive assessment platform (e.g., DCTclock) for early detection of Alzheimer's and other dementias, sold to clinicians and health systems. Comparable target use case to Neotiv's neotivCare®.
- Cumulus Neuroscience: Combines digital cognitive tests with EEG and other biomarkers for CNS clinical trials and early dementia detection. Overlaps with Neotiv in digital memory assessment for early-stage cognitive impairment.
- BrainCheck: Provides a digital cognitive assessment and care platform used by clinicians to detect and manage cognitive impairment. Similar product positioning to Neotiv for cognitive screening and monitoring.
- Savonix: Mobile digital cognitive assessment platform aimed at early detection of dementia and other conditions. Comparable in deploying app-based cognitive testing for screening and monitoring.
Others
- Cerveau Technologies: Provides tau PET imaging ligands used in Alzheimer's research and clinical trials. Adjacent rather than competitive — useful as a complementary diagnostic partner to Neotiv's digital cognitive tests.
- Biogen: Major Alzheimer's therapeutics company (e.g., aducanumab) with active interest in digital screening tools for patient identification. Not a direct competitor, but a plausible partner or customer for Neotiv in trial recruitment and pre-screening.
- Eisai: Developer of lecanemab and other Alzheimer's therapies. Comparable as an adjacent ecosystem participant rather than a competitor; relevant for Neotiv as a potential partner integrating digital screening into treatment pathways.
Market position
Customer concentration
Neotiv compliance and trust
Trust signalCompliance1 record
Neotiv financial estimates
Financial estimateRevenue estimate
Valuation estimate
Neotiv leadership team
Management profileNumber of profiles
Profiles5 records
Neotiv funding detail
Funding detailFunding overview
Funding rounds3 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Neotiv M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Neotiv
What does Neotiv do?
Neotiv develops and distributes the neotivCare® app, a CE-certified medical device that administers digital memory tests on a mobile platform to identify cognitive impairment at an early stage and support early Alzheimer's detection. The product targets individuals at risk of cognitive decline and is positioned as an accessible, non-invasive early screening tool for cognitive health.
Is Neotiv a public or private company?
Neotiv is a private company. It is classified as venture growth investor backed and is currently operating.
When was Neotiv founded?
Neotiv was founded in 2017. It employs 11 to 50 people.
Where is Neotiv based?
Neotiv is headquartered in Magdeburg, Germany, in the Europe region.
Who are Neotiv's main competitors?
Direct peers on record are Cambridge Cognition and Cogstate. Emerging players are Altoida, Linus Health, Cumulus Neuroscience, BrainCheck and Savonix. Others are Cerveau Technologies, Biogen and Eisai.
Does Neotiv have an API?
No public API is recorded for Neotiv.
What industry is Neotiv in?
Neotiv's product category is Digital Health / Cognitive Diagnostics. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HSABAEAH, Cognitive Stimulation & Reminiscence Therapy (Non-Clinical). Its SIC code is 7372.